About
Humacyte develops bioengineered, off-the-shelf acellular human vessels designed for use as implantable blood vessels to treat vascular diseases and provide durable vascular access for dialysis and other clinical indications.
Explore Humacyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.